JORDEN DAVID EMERSON (CEO, CFO) exercised options at NUO THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2026ACC: 0001437749-26-000431
DirectorOfficer· CEO, CFO
Since Aug 2018
-25.38K
Net shares
Net seller
$50.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
125K acquired · 150.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+125K
Price / share
$0.40
Trade value
$50K
% of position
6.4%
1/1/2026
1.95M→2.07M
Common Stock
Direct
Shares
−25.38K
Price / share
$1.97
Trade value
$50K
% of position
1.2%
1/1/2026
2.07M→2.05M
Total
Net shares
+99.62K
Net value
-$0.57
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | M · Option Exercise | +125K | $0.40 | $50K | 6.4% | 1.95M | 2.07M |
| Common Stock Direct | 1/1/2026 | F · Tax Withholding | −25.38K | $1.97 | $50K | 1.2% | 2.07M | 2.05M |
| Total | +99.62K | -$0.57 | ||||||
Derivative Transactions1
Option to purchase common stock
Direct
Converts to
Common Stock
125K shares
Shares
−125K
Strike price
0.40
Held after
0.00
Exercisable
—
12/31/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to purchase common stock Direct | Common Stock125K shares | 12/31/2018 | M · Option Exercise | −125K | 0.40 | — | 0.00 |